Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

26
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

20
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

209
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
209
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

13
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrence of Pulmonary Hypertension After Unilateral Lung Transplantation: Histological Evidence of Vasoconstrictive Mechanism.

Pulmonary circulation·2026
Same author

Persistent Severe Tricuspid Regurgitation After Mitral Transcatheter Edge-to-Edge Repair: Prognostic Implications of Guideline-Based Eligibility for Transcatheter Tricuspid Valve Intervention.

Structural heart : the journal of the Heart Team·2026
Same author

Intracardiac air mimicking an atrial septal occluder device during left atrial appendage closure.

Cardiovascular intervention and therapeutics·2026
Same author

GLP-1 Receptor Agonists in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives.

Nutrients·2026
Same author

Predictive value of simple echocardiographic parameters for screening pulmonary hypertension under the revised definition: a study for general hospitals.

Open heart·2026
Same author

Treatment strategies for pulmonary arterial hypertension associated with adult congenital heart diseases.

Expert review of clinical pharmacology·2026

Related Experiment Video

Updated: Jul 31, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K

Machine learning in cardiology: Clinical application and basic research.

Jin Komuro1, Dai Kusumoto1, Hisayuki Hashimoto1

  • 1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Journal of Cardiology
|May 4, 2023
PubMed
Summary

Machine learning, a type of artificial intelligence, is increasingly vital in medicine. This review highlights its advancements in clinical and basic cardiovascular research, utilizing diverse data types for better insights.

Keywords:
Basic researchClinical applicationMachine learning

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Related Experiment Videos

Last Updated: Jul 31, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Area of Science:

  • Artificial Intelligence
  • Medical Informatics
  • Bioinformatics

Background:

  • Machine learning (ML) is a rapidly advancing subfield of artificial intelligence with broad societal impact.
  • Its application is expanding significantly within the medical field, transforming data analysis and research.
  • ML encompasses supervised, unsupervised, and reinforcement learning, chosen based on data type and research goals.

Purpose of the Study:

  • To review recent advancements in machine learning applications within medicine.
  • To specifically focus on the use of ML in both clinical and basic cardiovascular research.
  • To underscore the growing relevance of ML in analyzing diverse medical data.

Main Methods:

  • Review of current literature on machine learning in medical and cardiovascular research.
  • Categorization of ML types (supervised, unsupervised, reinforcement) and their applications.
  • Analysis of ML utilization across various data types including electronic health records and omics data.

Main Results:

  • Machine learning is crucial for analyzing complex datasets like electronic health records, microarray data, and RNA sequences.
  • Significant progress has been made in applying ML to clinical cardiovascular studies.
  • ML is indispensable for advanced genomic and multi-omics analyses in basic research.

Conclusions:

  • Machine learning is a key technology driving innovation in cardiovascular medicine and research.
  • Its versatility allows for effective analysis of diverse data, from clinical records to genomic sequences.
  • Continued advancements in ML promise further breakthroughs in understanding and treating cardiovascular diseases.